发明授权
US08003787B2 Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
失效
磺酰亚胺取代的喹啉和喹唑啉衍生物作为激酶抑制剂
- 专利标题： Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
- 专利标题（中）： 磺酰亚胺取代的喹啉和喹唑啉衍生物作为激酶抑制剂
-
申请号： US12126437申请日： 2008-05-23
-
公开(公告)号： US08003787B2公开(公告)日： 2011-08-23
- 发明人: Knut Eis , Olaf Prien , Ulrich Lücking , Judith Günther , Dieter Zopf , Dirk Brohm , Verena Vöhringer , Elisabeth Woltering , Hartmut Beck , Mario Lobell , Volkhart Min-Jian Li , Susanne Greschat
- 申请人： Knut Eis , Olaf Prien , Ulrich Lücking , Judith Günther , Dieter Zopf , Dirk Brohm , Verena Vöhringer , Elisabeth Woltering , Hartmut Beck , Mario Lobell , Volkhart Min-Jian Li , Susanne Greschat
- 申请人地址： DE Berlin
- 专利权人： Bayer Schering Pharma AG
- 当前专利权人： Bayer Schering Pharma AG
- 当前专利权人地址： DE Berlin
- 代理机构： Millen, White, Zelano & Branigan, P.C.
- 优先权： DE102007024470 20070524; EP07076116 20071220
- 主分类号： C07D239/86
- IPC分类号： C07D239/86
摘要：
The present invention relates to a quinoline or quinazoline derivative having the general formula (A): in which R3, R4, W, Y and Q are indicated in the description and the claims, the use of the compounds of the general formula (A) for the treatment of various disorders, and the preparation of compounds of the general formula (A).